Abstract
It’s over quarter-century since the working group chaired by Gordon Guyatt introduced evidence-based medicine (EBM) as a ‘new paradigm for medical practice’ and 35 years since the foundations of evidence-based medicine were established by David Sackett. EBM has transformed medical decision making and practice in the last quarter century. EBM was established to define what constitutes acceptable evidence, namely, that which is scientific rather than personal. Defined as ‘the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients’, Sackett proposed that EBM considered the best available evidence, clinical skills and the patient’s situation and expectations. The popularity and adoption of EBM has led to globally established systems to review medical evidence that include the Cochrane Collaboration, the Oxford Centre for Evidence Based Medicine an established approach to the evaluation of clinical evidence proposed in 2000, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE). However, some have challenged the reliance on EBM, suggesting that the evidence generated is overly generalisable, is limited to treatment-efficacy and does not account for other attributes and issues relating to interventions, and that it is open to exploitation. The following chapter describes the rise and development of EBM, the systems established to review medical evidence and the criticisms that have evolved.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–2.
Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. Boston: Little Brown; 1991.
Guyatt G. Evidence-based medicine. Ann Intern Med. 1991;14(Supp 2):A-16.
Sackett D. How to read clinical journals: I. why to read them and how to start reading them critically. Can Med Assoc J. 1981;124(5):555–8.
Smith R, Rennie D. Evidence based medicine—an oral history. BMJ. 2014;348(21):g371.
Zimerman A. Evidence-based medicine: a short history of a modern medical movement. American Medical Association Journal of Ethics. 2013;15(1):71–6.
Haynes B. Advances in evidence-based information resources for clinical practice. ACP J Club. 2000;132(1):A11–4.
Feinstein AR. Clinical Judgement. Baltimore, MD: Williams & Wilkins; 1967.
Cochrane AL. Effectiveness and efficiency: random reflections on health services. London: Nuffield Provincial Hospitals Trust; 1972.
Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA. 1992;268(17):2420–5.
Eddy DM. Practice Policies: Guidelines for Methods. JAMA. 1990;263(13):1839–41.
Eddy DM. Guidelines for policy statements. JAMA. 1990;263(16):2239–43.
Eddy DM. Evidence-based medicine: a unified approach. Health Aff. 2005;24(1):9–17.
Sur RL, Dahm P. History of evidence-based medicine. Indian J Urol. 2011;4:487–9.
Cochrane AL, Cox JG, Jarman TF. Pulmonary tuberculosis in the Rhondda Fach; an interim report of a survey of a mining community. Br Med J. 1952;2:843–53.
Chalmers I, Enkin M, Keirse MJ, editors. Effective Care in Pregnancy and Childbirth. New York, NY: Oxford University Press; 1989.
Dawes M. EBM Volume 5 July/August 2000 103. https://ebm.bmj.com/content/5/4/102.
Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1989;95:2S–4S.
OCEBM Table of Evidence Working Group: Howick J, Chalmers I (James Lind Library), Glasziou P, Greenhalgh T, Heneghan C, Liberati A, Moschetti I, Phillips B, Thornton H, Goddard O, Hodgkinson M. The Oxford 2011 levels of evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653.
Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendation (Version 3.2 ed.); 2009.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed). 2008;336(7650):924–6.
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2011;343:d5928.
Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011. Oxford. Asp; 2011
Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical research ed). 2016;355:i4919.
Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. Going from evidence to recommendations. BMJ (Clinical research ed). 2008;336(7652):1049–51.
La Caze A. The role of basic science in evidence-based medicine. Biology & Philosophy. 2011;26(1):81–98.
Timmermans S, Berg M. The gold standard: the challenge of evidence-based medicine and standardization in health care. Philadelphia: Temple University Press; 2003.
Feinstein AR, Massa RD. Problems of ‘evidence’ in ‘evidence-based medicine’. Am J Med. 1997;103:529–35.
Fava GA, Guidi J, Rafanelli C, Sonino N. The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment. Psychother Psychosom. 2015;84(1):1–3.
Richardson WS, Doster LM. Comorbidity and multimorbidity need to be placed in the context of a framework of risk, responsiveness, and vulnerability. J Clin Epidemiol. 2014;67:244–6.
Berlin JA, Golub RM. Meta-analysis as evidence: building a better pyramid. JAMA. 2014;312:603–5.
Dechartres A, Altman DG, Trinquart L, et al. Association between analytic strategy and estimates of treatment outcomes in meta-analyses. JAMA. 2014;312:623–30.
Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med. 2016 Aug;21(4):125–7.
James J. Reviving Cochrane’s contribution to evidence-based medicine: bridging the gap between evidence of efficacy and evidence of effectiveness and cost-effectiveness. Eur J Clin Investig. 2017;47(9):617–21.
Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.
Greenhalgh T, Howick J, Maskrey N. Evidence based medicine: a movement in crisis? BMJ. 2014;348:g3725.
Lavis JN, Davies HT, Gruen RL, Walshe K, Farquhar CM. Working within and beyond the Cochrane collaboration to make systematic reviews more useful to healthcare managers and policy makers. Healthcare Policy. 2006;1:21–33.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dimitri, P. (2021). The Evolution of Evidence Based Clinical Medicine. In: Godbole, P., Wilcox, D.T., Koyle, M.A. (eds) Practical Pediatric Urology. Springer, Cham. https://doi.org/10.1007/978-3-030-54020-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-54020-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54019-7
Online ISBN: 978-3-030-54020-3
eBook Packages: MedicineMedicine (R0)